ID Biomedical signs distribution agreements for flu vaccine &lt;b&gt;...&lt;/b&gt; NEW YORK, December 6 (newratings.com) - ID Biomedical Corp (IDBE.NAS) announced today that it has signed a ten-year US distribution agreement for its Fluviral treatment, expected to generate \$2.5 billion in sales and offset the shortage of flu vaccines 